Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell
Advanced Renal Cell Carcinoma
Renal Cancer
Renal Neoplasm
Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Clear-cell Metastatic Renal Cell Carcinoma
Carcinoma, Renal Cell Metastasis
Advanced or Metastatic Renal Cell Carcinoma
Carcinoma, Renal Cell, Advanced
Metastatic Renal Cell Cancer
Metastatic Renal Cell Carcinoma ( mRCC)
Metastatic/Advanced Renal Cell Carcinoma

Interventions

BIOLOGICAL: PF-08634404
DRUG: Combination 1
DRUG: Combination 2

Sponsor

Pfizer